Clinical pharmacology of oral gemcitabine in patients with advanced solid tumors

被引:0
|
作者
Veltkamp, S. A.
Callies, S.
Nol, A.
Visseren-Grul, C. M.
Slapak, C.
Beijnen, J. H.
Schellens, J. H. M.
机构
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:735 / 735
页数:1
相关论文
共 50 条
  • [41] A phase I study of oral ixabepilone in patients with advanced solid tumors
    John F. Deeken
    John L. Marshall
    Michael J. Pishvaian
    Jimmy Hwang
    Christoph M. Ahlers
    Pamela L. Clemens
    Susan M. Parker
    Lisa Iacono
    Patricia M. LoRusso
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 1071 - 1078
  • [42] A phase I study of topotecan and gemcitabine in advanced solid tumors
    Serna, Derek S.
    Bekaii-Saab, Tanios
    Kraut, Eric H.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1390 - 1394
  • [43] Phase I trial of gemcitabine and paclitaxel in advanced solid tumors
    Lim, N
    Lara, PN
    Lau, DHM
    Edelman, MJ
    Tanaka, M
    Al-Jazayrly, G
    Houston, J
    Lauder, I
    Gandara, DR
    CANCER INVESTIGATION, 2003, 21 (01) : 7 - 13
  • [44] Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors
    Ralf Axel Hilger
    Andreas Harstrick
    Wilfried Eberhardt
    Carsten Oberhoff
    Matthias Skorzec
    Joachim Baumgart
    Siegfried Seeber
    Max Ernst Scheulen
    Cancer Chemotherapy and Pharmacology, 1998, 42 : 99 - 104
  • [45] Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors
    Hilger, RA
    Harstrick, A
    Eberhardt, W
    Oberhoff, C
    Skorzec, M
    Baumgart, J
    Seeber, S
    Scheulen, ME
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (02) : 99 - 104
  • [46] Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors
    Galsky, Matthew D.
    Posner, Marshall
    Holcombe, Randall F.
    Lee, Karen M.
    Misiukiewicz, Krzysztof
    Tsao, Che-Kai
    Godbold, James
    Soto, Rothschild
    Gimpel-Tetra, Kiev
    Lowe, Nancy
    Oh, William K.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (03) : 465 - 471
  • [47] Phase I study of oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients (pts) with advanced solid tumors
    Koolen, S.
    Witteveen, P. O.
    Garcia-Ribas, I.
    Callies, S.
    Andre, V.
    Kronemeijer, R. H.
    Nol, A.
    Beijnen, J. H.
    Voest, E. E.
    Schellens, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors
    Matthew D. Galsky
    Marshall Posner
    Randall F. Holcombe
    Karen M. Lee
    Krzysztof Misiukiewicz
    Che-Kai Tsao
    James Godbold
    Rothschild Soto
    Kiev Gimpel-Tetra
    Nancy Lowe
    William K. Oh
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 465 - 471
  • [49] Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors
    Paz-Ares, Luis
    Forster, Martin
    Boni, Valentina
    Szyldergemajn, Sergio
    Corral, Jesus
    Turnbull, Samantha
    Cubillo, Antonio
    Fernandez Teruel, Carlos
    Lopez Calderero, Iker
    Siguero, Mariano
    Bohan, Patrick
    Calvo, Emiliano
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) : 198 - 206
  • [50] Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors
    Luis Paz-Ares
    Martin Forster
    Valentina Boni
    Sergio Szyldergemajn
    Jesús Corral
    Samantha Turnbull
    Antonio Cubillo
    Carlos Fernandez Teruel
    Iker López Calderero
    Mariano Siguero
    Patrick Bohan
    Emiliano Calvo
    Investigational New Drugs, 2017, 35 : 198 - 206